Breakthrough technologies for health preservation
Theranostics – the trend of medicine

- Monoclonal antibodies for targeted drug delivery.
- Nanocomplexes (iron oxide, nanorubins and nanophosphores, silicon) for imaging, chemotherapy, thermal effects on cancer cells initiated by alternating magnetic fields, ultrasound, etc.
- Targeted diagnostic and therapeutic tandems based on radioactive isotopes.
- Promotion and positioning of the University as a leading organization in the field of theranostics of oncological diseases.
- Creation of a modern base of scientific research in the field of medical radiation technologies.
- Formation of highly qualified personnel potential in the field of medical radiation technologies.
- Training of specialists in the field of nuclear medicine who are competitive on the world market.
- Formation of a base for sustainable financing of scientific research in the field of nuclear medicine.
- Creation of a world-class scientific and technical foundation for the development of fundamental and applied research in the field of medical engineering.
- The directions of fundamental research are Targeted diagnostic and therapeutic tandems based on radioactive isotopes. — Complex methods of spatial visualization of malignant neoplasms based on radionuclide diagnostics for computer planning of intraoperative therapy of the tumor bed and lymphogenic metastasis zones. Potential for the development of fundamental research
- Development of competence in the field of nuclear physics, biotechnology, radiochemistry, organic chemistry, toxicology, pharmacy, experimental and clinical nuclear medicine. Experience in creating a wide range of diagnostic and therapeutic radiopharmaceuticals based on isotopes 199Tl, 123I, 99mTc.
- Expansion of the material and technical base and development of basic research infrastructure. Availability of basic electrophysical installations.
- Entry and active interaction with the technology platform "Medicine of the Future".
- Formation of a stable consortium in the field of "Nuclear Medicine" as part of the leading Russian and foreign scientific and educational centers.
- Presentation of research results in leading scientific publications and at international scientific conferences.
- Automated module for obtaining technetium-99m preparations from irradiated molybdenum of natural composition.
- The method of synthesis of targeting proteins with ankyrin repeats is DARPins (Designed Ankyrin Repeat Proteins), which have a high affinity for the HER2/neu cancer marker.
- Method of obtaining and activating fatty carboxylic acids for effective binding of antibodies to 99mTs.
- Physical regularities of changes in the cross section of the nuclear reaction (186W(d, 2n) 186Re) and the yield of 186Re during the interaction of deuterons with an energy of 13 MeV with a thick metal tungsten target.
- Evaluation of the operating time of 186Re from a tungsten target, showing the possibility of using a cyclotron to create radiopharmaceuticals based on the 186Re isotope for 4,000 patients per year.
- An electronic radiation source based on a small-sized pulsed betatron with a beam energy of up to 7 MeV and a generation frequency of 400 Hz.
- Dosimetry of an intraoperative betatron electron beam at a therapeutic electron energy of 6 MeV in aqueous and solid-state phantoms.
- Mathematical apparatus of a linear-quadratic model of intraoperative therapy planning based on the calculation of radiation dose distribution for various types of applicators.
- The concept of online monitors based on a pass-through ionization chamber and luminescent material using silicon photomultipliers (Si-PMT).
- Network Master's program "Nuclear Medicine".